CNCR
Loncar Cancer Immunotherapy ETF
1W: +0.0%
1M: -11.3%
3M: -16.4%
1Y: -38.1%
3Y: -36.0%
5Y: -62.0%
$9.02
Last traded 2025-06-03 — delisted
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Key Statistics
AUM$7M
Holdings31
Top 10 Wt34.4%
Volume0
Avg Volume2,147
Beta0.96
Portfolio Fundamentals
P/E35.1
P/B6.0
Div Yield0.39%
ROE12.4%
% Profitable29%
Inception2015-10-14
Sector Allocation
Healthcare
96.6%
Financial Services
3.3%
Other
0.1%
Top 10 Holdings
| # | Name | Ticker | Weight % | Market Value | Shares |
|---|---|---|---|---|---|
| 1 | Instil Bio, Inc. | TIL | 3.59% | $963,402 | 93,230 |
| 2 | Replimune Group, Inc. | REPL | 3.54% | $949,984 | 47,193 |
| 3 | Iovance Biotherapeutics, Inc. | IOVA | 3.47% | $931,199 | 67,485 |
| 4 | Zymeworks Inc. | ZYME | 3.45% | $925,832 | 41,554 |
| 5 | argenx SE | ARGX | 3.42% | $917,781 | 5,056 |
| 6 | Genmab A/S | GMAB | 3.42% | $917,781 | 35,793 |
| 7 | AstraZeneca PLC | AZN | 3.39% | $909,731 | 26,541 |
| 8 | CRISPR Therapeutics AG | CRSP | 3.39% | $909,731 | 12,623 |
| 9 | Bristol-Myers Squibb Company | BMY | 3.39% | $909,731 | 23,173 |
| 10 | Xencor, Inc. | XNCR | 3.37% | $904,363 | 41,933 |
Recent Holding Changes
No recent changes